New and Generic Drug Approvals
buprenorphine hydrochloride tablets, (Subutex) (treatment of opiate dependence) Roxane Laboratories, Inc., Tentative Approval
cetirizine hydrochloride syrup, (Zyrtec) (allergies) Apotex Corp., Approval
cetirizine hydrochloride syrup, Perrigo Israel Pharmaceuticals, Ltd.., Approval
Claritin (loratadine) (allergies) Capsules, Schering-Plough HealthCare Products, Approval hydromorphone hydrochloride injection, (pain relief) (Dilaudid) Hospira, Inc., Approval
metoprolol tartrate tablets, (Lopressor)Ohm Laboratories, Inc., Approval
trandolapril tablets, (Mavik)(hypertension)Glenmark Generics Inc., USA, Approval
Trivaris (triamcinolone acetonide) (occular inflammation)Injectable Suspension, Allergan, Inc., Approval
June 18, 2008
Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules, Eli Lilly and Co., Approval
Requip XL (ropinirole) Extended-Release Tablets, (Parkinson's)GlaxoSmithKline, Approval
venlafaxine hydrochloride tablets, (Effexor) (depression)Caraco Pharmaceutical Laboratories, Ltd., Approval
venlafaxine hydrochloride tablets, Mylan Pharmaceuticals, Inc., Approval
venlafaxine hydrochloride tablets, Pliva Hrvatska, Approval
venlafaxine hydrochloride tablets, Sandoz, Inc., Approval
venlafaxine hydrochloride tablets, Zydus Pharmaceuticals USA, Inc., Approval
Friday, June 20, 2008
FDA Update, 6/20/2008
Subscribe to:
Post Comments (Atom)
1 comment:
Great thoughts you got there, believe I may possibly try just some of it throughout my daily life.
Great thoughts you got there, believe I may possibly try just some of it throughout my daily life.
Post a Comment